AI-generated summary
The authors studied low-intensity laser therapy, given as intravenous blood irradiation, transrectal and transurethral prostatic irradiation, or a combination, before surgery in men with benign prostatic hyperplasia. Local and combined laser therapy were reported to improve immune markers and reduce bacteria in urine and prostate tissue, and preoperative laser therapy was associated with fewer postoperative pyoinflammatory complications and shorter hospital stays. The abstract does not report a participant count.
- Who or what was studied
- Patients with benign prostatic hyperplasia undergoing preoperative preparation for surgery
- Limits stated in the abstract
- The abstract does not state the number of patients, the control design, or the statistical certainty of the reported effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.